A Multicenter, Observational Study to Evaluate the Association Between Postprandial Urinary C-peptide Creatinine Ratio and the Treatment Response to Liraglutide in Patients with Type 2 Diabetes Mellitus.
Phase of Trial: Phase IV
Latest Information Update: 02 Dec 2015
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 02 Dec 2015 New trial record